Prepare for your visit
Paul C Browne
Maternal & Fetal Medicine · West Columbia, SC · NPI 1366496465
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$283.69
in general payments reported to CMS, 2019-2025 · $29.96 in 2025
The $29.96 reported for 2025 was less than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Who reported paying
General payments only, top 6 by amount.
- Covidien LP $72.18
- Daiichi Sankyo INC. $31.61
- Abbvie INC. $29.96
- Bayer Healthcare Pharmaceuticals INC. $26.66
- Dexcom, INC. $24.68
- Alexion Pharmaceuticals, INC. $19.63
Drugs and devices associated with these payments
Vraylar Liletta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Paul Browne listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1227801/paul-c-browne